Search results

Page results

• Chronic lymphocytic leukaemia (CLL) 

  UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.

• Leukaemia, chronic myeloid (CML) 

  UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia.

• Lymphoma, Non-Hodgkin 

  UCLH is considered a centre of excellence in the management of patients with Hodgkin’s and non-Hodgkin’s lymphoma.

• Stem cell and bone marrow transplants (BMT) 

  The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.

• Haemophilia and acquired bleeding disorders

  UCLH is a designated Haemophilia Centre providing a 24/7 service for patients, including those needing treatment with blood products and clotting factor medications.

• Thalassaemia

  Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.

• Diet and Nutrition (Post-COVID Service)

  This patient information offers advice for patients suffering from long COVID regarding a healthy diet and nutrition.

• Speech and language therapy service head and neck cancer

  The head and neck speech and language therapy team provide a highly specialist service to both inpatients and outpatients who may experience difficulty swallowing or speaking following treatment for head and neck cancer.

• Series No.51 - Radiotherapy to the bladder

  This page is for patients who are receiving radiotherapy to the bladder.

• Post-COVID follow-up service

  The UCLH post-COVID service is the lead provider for North Central London (NCL) and works with borough based services to provide support and assessment for patients with ongoing symptoms (long covid) following COVID-19 infection.